主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SNTI
#4018
Senti Biosciences, Inc. Common Stock
0.931
5
USD
-6.40%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
-6.40%
每月变动
-2.15%
6个月变化
-2.15%
年变化
-2.15%
前一天收盘价
0.995
2
Open
0.931
5
Bid
0.931
5
Ask
0.934
5
Low
0.931
5
High
0.931
5
交易量
6
市场
股票
医疗保健
SNTI
Open full chart
Financials
Overview
声明
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Cash from operating activities
7.87 M
13.5 M
14.05 M
13.07 M
9.45 M
50.07 M
Cash from investing activities
30 K
-11 K
0
184 K
0
173 K
Cash from financing activities
2.44 M
51.29 M
414 K
183 K
124 K
52.01 M
Free cash flow
7.87 M
13.49 M
14.05 M
12.88 M
9.45 M
49.87 M
新闻
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories! - TipRanks.com
Why Is Gene Therapy Focused Senti Bio Stock Falling Today? - Senti Biosciences (NASDAQ:SNTI)
Senti Bio的SENTI-202在AML临床试验中显示出有希望的结果
Senti Bio’s SENTI-202 shows promising results in AML clinical trial
Senti Bio股价在癌症疗法试验结果积极后飙升
Senti Bio stock soars after positive cancer therapy trial results
Leerink Partners 以"跑赢大盘"评级开启对 Senti Biosciences 股票的覆盖
Senti Bio将在ASH会议上展示SENTI-202的最新临床数据
Senti Bio to present updated clinical data on SENTI-202 at ASH meeting
H.C. Wainwright 给 Senti Biosciences 股票评级为"买入"
Senti Biosciences stock rating initiated at Buy by H.C. Wainwright
Senti Biosciences completes dose finding in AML therapy trial